Our Drug Substance CDMO Services offer integrated solutions for the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. At Lianhe Aigen, we provide tailored CDMO services to support the entire drug lifecycle, from preclinical trials to commercial production.

Key highlights of our Drug Substance CDMO Service include:

Process Development: Robust and scalable processes to optimize yields and reduce costs.

GMP Manufacturing: Regulatory-compliant production for clinical and commercial use.

Advanced Technologies: Expertise in flow chemistry, solid-state chemistry, and more.

Quality Assurance: Rigorous quality control systems to ensure product integrity and compliance.

Partner with us for seamless drug substance development and reliable manufacturing support, empowering you to focus on innovation and patient care.